• Explore /
  • Poster
  • / Association of tumor genetics with outcomes in patients (pts) with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) treated with <sup>177</sup>Lu-PSMA-617.

Association of tumor genetics with outcomes in patients (pts) with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) treated with 177Lu-PSMA-617.

Abstract Poster

Authors

Justine Panian

Justine Panian

University of California, San Diego, San Diego, CA

Justine Panian , Nicholas Henderson , Pedro C. Barata , Mehmet Asim Bilen , Laura Graham , Elisabeth I. Heath , Daniel Herchenhorn , Clara Hwang , Deepak Kilari , Vadim S Koshkin , Jones T. Nauseef , Alexandra Sokolova , Yousef Zakharia , Michael Thomas Schweizer , Tanya B. Dorff , Andrew J. Armstrong , Ajjai Shivaram Alva , Rana R. McKay

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 5050)

DOI

10.1200/JCO.2024.42.16_suppl.5050

Abstract #

5050

Poster Bd #

456

Abstract Disclosures

Similar Posters

First Author: Anis Hamid

First Author: Aishwarya Subramanian

Poster

2023 ASCO Genitourinary Cancers Symposium

<span>Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer.</span>

Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer.

First Author: Samir Zaidi

First Author: Anis Hamid